Notice of Establishment, 59534 [E7-20692]
Download as PDF
<![CDATA[
59534
Federal Register / Vol. 72, No. 203 / Monday, October 22, 2007 / Notices
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20692 Filed 10–19–07; 8:45 am]
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20701 Filed 10–19–07; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention (CDC)
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Establishment
ebenthall on PRODPC61 with NOTICES
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention (CDC).
[FR Doc. E7–20717 Filed 10–19–07; 8:45 am]
Notice of Establishment
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Secretary, Department
of Health and Human Services (HHS),
announces the establishment of the
Board of Scientific Counselors, National
Center for Health Marketing (NCHM).
This board is established to ensure
that the national center has access to
external viewpoints, the capacity to
conduct peer review of scientific
programs, and perform second level
peer-review of research applications.
The Board of Scientific Counselors,
NCHM will advise the Secretary, HHS;
and the Director, Centers for Disease
Control and Prevention; concerning
strategies and goals for the programs
and research within the national
centers; shall conduct peer-review of
scientific programs; and monitor the
overall strategic direction and focus of
the national centers. The board, after
conducting its periodic reviews, shall
submit a written description of the
results of the review and its
recommendations to the Director, CDC.
The board shall also perform secondlevel peer review of applications for
grants-in-aid for research and research
training activities, cooperative
agreements, and research contract
proposals relating to the broad areas
within the national centers.
For information, contact Dr. Kathleen
McDuffie, Executive Secretary, Centers
for Disease Control and Prevention, of
the Department of Health and Human
Services, 1600 Clifton Road, N.E.,
Mailstop E21, Atlanta, Georgia 30333,
telephone 404/498–1114 or fax 404/
498–1112.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Secretary, Department
of Health and Human Services (HHS),
announces the establishment of the
Board of Scientific Counselors, National
Center for Injury Prevention and Control
(NCIPC).
This board is established to ensure
that the national center has access to
external viewpoints, the capacity to
conduct peer review of scientific
programs, and perform second level
peer-review of research applications.
The Board of Scientific Counselors,
NCIPC will advise the Secretary, HHS;
and the Director, Centers for Disease
Control and Prevention (CDC);
concerning strategies and goals for the
programs and research within the
national centers; shall conduct peerreview of scientific programs; and
monitor the overall strategic direction
and focus of the national centers. The
board, after conducting its periodic
reviews, shall submit a written
description of the results of the review
and its recommendations to the
Director, CDC. The board shall also
perform second-level peer review of
applications for grants-in-aid for
research and research training activities,
cooperative agreements, and research
contract proposals relating to the broad
areas within the national centers.
For information, contact Dr.
Gwendolyn Cattledge, Executive
Secretary, Centers for Disease Control
and Prevention, of the Department of
Health and Human Services, 4770
Buford Highway, NE., Mailstop K02,
Atlanta, Georgia 30341, telephone 770/
488–4655 or fax 770/488–4422.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the CDC
and the Agency for Toxic Substances
and Disease Registry.
Ethics Subcommittee, Advisory
Committee to the Director (ACD),
Centers for Disease Control and
Prevention (CDC)
VerDate Aug<31>2005
16:04 Oct 19, 2007
Jkt 214001
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC announces the
following meeting for the
aforementioned subcommittee:
Times and Dates:
1 p.m.–5:30 p.m., November 15, 2007.
8:30 a.m.–3:30 p.m., November 16, 2007.
Place: CDC, Century Center Campus, 1825
Century Boulevard, Conference Room 1 A/B,
Atlanta, Georgia 30345.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 70 people. To
accommodate public participation in the
meeting, a conference telephone line will be
available. The public is welcome to
participate during the public comment
periods by calling (866) 919–3560 and
entering code 4168828. The public comment
periods are tentatively scheduled from 4:45
p.m.–5 p.m. on November 15, 2007 and from
3 p.m.–3:15 p.m. on November 16, 2007.
Purpose: The Ethics Subcommittee will
provide counsel to the ACD, CDC regarding
a broad range of public health ethics
questions and issues arising from programs,
scientists, and practitioners.
Matters to be Discussed: Agenda items will
include: Ethical Guidance for Public Health
Emergency Preparedness and Response;
Ethical Guidance for Non-Research Data
Collections; and Updates on Activities
relating to CDC Partnerships, Genomics Best
practices, and Pandemic Influenza
Preparedness. Agenda items are subject to
change as priorities dictate.
For security reasons, members of the
public interested in attending the meeting
should contact the person below. The
deadline for notification of attendance is
November 9, 2007.
Contact Person for More Information: Drue
Barrett, Ph.D., Designated Federal Official,
Ethics Subcommittee, CDC, 1600 Clifton
Road, NE., M/S D–50, Atlanta, Georgia
30333. Telephone (404) 639–4690. E-mail:
dbarrett@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 72, Number 203 (Monday, October 22, 2007)]
[Notices]
[Page 59534]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20692]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention (CDC)
Notice of Establishment
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. Appendix 2), the Secretary, Department of Health and Human
Services (HHS), announces the establishment of the Board of Scientific
Counselors, National Center for Health Marketing (NCHM).
This board is established to ensure that the national center has
access to external viewpoints, the capacity to conduct peer review of
scientific programs, and perform second level peer-review of research
applications.
The Board of Scientific Counselors, NCHM will advise the Secretary,
HHS; and the Director, Centers for Disease Control and Prevention;
concerning strategies and goals for the programs and research within
the national centers; shall conduct peer-review of scientific programs;
and monitor the overall strategic direction and focus of the national
centers. The board, after conducting its periodic reviews, shall submit
a written description of the results of the review and its
recommendations to the Director, CDC. The board shall also perform
second-level peer review of applications for grants-in-aid for research
and research training activities, cooperative agreements, and research
contract proposals relating to the broad areas within the national
centers.
For information, contact Dr. Kathleen McDuffie, Executive
Secretary, Centers for Disease Control and Prevention, of the
Department of Health and Human Services, 1600 Clifton Road, N.E.,
Mailstop E21, Atlanta, Georgia 30333, telephone 404/498-1114 or fax
404/498-1112.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the CDC and the Agency for Toxic Substances and Disease
Registry.
Dated: October 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention (CDC).
[FR Doc. E7-20692 Filed 10-19-07; 8:45 am]
BILLING CODE 4163-18-P
